Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,941 public trials 2,019 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma

NCT02544308

Conditions
Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, +4 more
Locations
  • Royal United Hospital Bath, United Kingdom
  • Blackpool Victoria Hospital Blackpool, United Kingdom
  • University Hospital Wales Cardiff, United Kingdom
  • Velindre Cancer Centre Cardiff, United Kingdom
View all 13 locations
View Trial Details
Active, Not Recruiting

Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma

NCT02415413

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Hospital Clínic de Barcelona Barcelona, Spain
  • Hospital Universitari Germans Trias i Pujol Barcelona, Spain
  • Hospital Clínico San Carlos Madrid, Spain
  • Hospital Universitario 12 de Octubre Madrid, Spain
View all 16 locations
View Trial Details
Active, Not Recruiting

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

NCT01744223

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +16 more
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University Hospitals of Cleveland Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

NCT03301168

Conditions
Acute Lymphoblastic Leukemia, Anemia, Anemia, Aplastic, +34 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant

NCT02477878

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
Locations
  • BMT Program at Northside Hospital Atlanta, Georgia, United States
  • University of Kansas Westwood, Kansas, United States
  • Roswell Park Buffalo, New York, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Active, Not Recruiting

Multi-Center Study of Sensory Stimulation to Improve Brain Function

NCT03556280

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +26 more
Locations
  • Brain Matters Research Delray Beach, Florida, United States
  • Brain Matters Research Stuart, Florida, United States
  • ActivMed Practices & Research, Inc Methuen, Massachusetts, United States
  • Boston Center for Memory Newton, Massachusetts, United States
View Trial Details
Active, Not Recruiting

An Intensive Program With Quadruplet Induction and Consolidation Plus Tandem Autologous Stem Cell Transplantation in Newly Diagnosed High Risk Multiple Myeloma Patients

NCT03606577

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CHU de Nantes Nantes, Pays de la Loire Region, France
  • CHU Caen Caen, France
  • CHRU Dijon Dijon, France
  • CHRU - Hôpital A.Michallon Grenoble, France
View Trial Details

Related conditions